AddThis Social Bookmark Button  what's this?

News by Subject

List and find news items by the subject covered

Subject A-Z

To view a list of news subjects currently covered, please select a subject initial letter from the line below.

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z


News items on 'Oseltamivir'

Page 1 of 1

HPA statement on possible transmission

(Health Protection Agency 20/11/2009)

The HPA is working with the Public Health Service of Wales to investigate a number of possible cases of person to person transmission of oseltamivir resistant swine flu. To date, a total of nine H1N1v confirmed cases have been reported amongst patients on a hospital ward in Wales. Five of these cases are known to be resistant to oseltamivir, one is sensitive and for three resistance status is presently unknown. The virus has emerged in a group of particularly vulnerable individuals.

Tamiflu-Resistant Swine Flu Found in Canadian Father

(World health - EU Monitor 12/11/2009)

Researchers report that a father in a Canadian family developed a strain of the H1N1 swine flu that was resistant to the antiviral Tamiflu, after being given the drug to prevent the disease. To date, the World Health Organization has reported some 45 cases of H1N1 swine flu that were resistant to Tamiflu, which is why the U.S. Centers for Disease Control and Prevention and others caution against using Tamiflu to prevent the disease in people who are symptomless.

Tamiflu 'shelf-life decision' up to countries

(World health - EU Monitor 18/08/2009)

The World Health Organisation said today it was up to national regulatory authorities to decide whether to extend the shelf life of the flu drug Tamiflu by two years, as recommended by Swiss drug maker Roche. The United States, Canada, Australia, Hong Kong and the European Union's drug watchdog have extended Tamiflu's shelf life to seven years from five after company data showed the active ingredient's longer stability, a Roche spokeswoman said.

Tamiflu nearly killed my daughter, says TV presenter

(The Scotsman 12/08/2009)

ANDREW Castle's daughter Georgina was given Tamiflu after an outbreak of swine flu among pupils at her private school in London in May. The tennis player turned breakfast TV presenter said the 16-year-old was not diagnosed with the virus before she was given the drug - and suffered an asthma attack the next day. Castle said: "She had asthma, she was showing flu-like symptoms, she took Tamiflu and almost died. "We saw a respiratory collapse through it and it almost cost my elder child her life."

Tamiflu children suffer sickness and nightmares

(The Scotsman 31/07/2009)

MORE than half of children taking Tamiflu experience side effects such as nausea and nightmares, two studies show. Data from children at three schools in London and one in south-west England showed many suffered such problems, including difficulty sleeping and feeling sick. The researchers behind one study said that children may have attributed symptoms due to other illnesses to Tamiflu, but say: "This is unlikely to account for all the symptoms experienced."

Patients suffer bad reaction to swine flu treatment

(World health - EU Monitor 27/07/2009)

The agency that licenses medicines in Britain has received 150 reports of suspected adverse reactions to the Tamiflu treatment for swine flu. The figure was released yesterday as GPs said some patients were choosing not to take the drug because of concerns about the possible side effects. The MHRA said the 150 reports received within the UK up until July 23 mention 241 separate side effects, most of which were mild and already recognised as linked with the anti-viral drug.

Inventor of Tamiflu profits from swine flu pandemic

(World health - EU Monitor 27/07/2009)

Swine flu may be feared by millions around the world but for one man the global pandemic has been very good news indeed. Dr. Norbert Bischofberger, 55, is the inventor of Tamiflu, the only medication on the market to treat the virus. He has made millions from the drug, but colleagues have said it was science, not money, that motivated him. A graduate of Innsbruck, Zurich and Harvard universities, Dr Bischofberger headed a research team to create Tamiflu, for US Gilead Sciences in the 1990s.

Sainsbury's says no to Tamiflu in bid to keep people with virus out of its stores

(The Scotsman 25/07/2009)

SAINSBURY'S is to opt out of distributing Tamiflu, because of fears it might encourage people with the virus into its supermarkets. While some the company's in-store pharmacies are supplying the drug as an "interim measure", there are no plans for the chain to become an official collection point. Tesco and Asda have signed up some of their pharmacies as collection points for people needing Tamiflu.

Page 1 of 1